Tecentriq and Avastin Liver Cancer Combo Linked to Patient Deaths in Early Trials
Some patient deaths have been linked to a clinical trial using a combination of Tecentriq and Avastin to prevent the return of liver cancer.
Tag Archives: Tecentriq
-
-
Keytruda, Tecentriq Get New Bladder Cancer Restrictions From FDA
The FDA announced new bladder cancer restrictions on the use of Keytruda and Tecentriq, following indications that they could lower survival rates for some patients.
-
Keytruda, Tecentriq Side Effects May Decrease Survival Chances In Some Patients: FDA
An FDA warning indicates that Keytruda and Tecentriq may decrease the risk of survival in certain metastatic urothelial cancer patients.
-
Clinical Trial for Tecentriq-Cotellic Combo Halted After Patient Deaths
Roche has temporarily halted a clinical trial of a combination of the cancer drugs Tecentriq and Cotellic following the deaths of several patients involved in the study.
-
Taxotere Found To Have More Side Effects, Lower Survival Rate Than Tecentriq: Study
A new study raises questions about the safety and effectiveness of Taxotere, which underperformed in both survival rates and side effects when compared to Tecentriq for treatment of lung cancer.
